Atlas Trials

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

Clinical trial NCT06574698 · RECRUITING

Trial details

NCT number
NCT06574698
Sponsor
Guangzhou Women and Children's Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
NeuroblastomaGD2 Antibody (Naxitamab)
Start date
2024-05-06
Primary completion
2029-12-31
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.